Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Under the license agreement with Chugai Pharmaceutical Co., Ltd, Lilly has worldwide development and commercialization rights to orforglipron
In addition, new drugs such as tirzepatide have come onto the market, expanding the therapeutic options for successful treatment of T2DM and obesity
The 10ml vial provides a convenient size for multiple medication reconstitutions, making it a practical choice for healthcare professionals
SELECT demonstrated a 20% relative risk reduction in time to first occurrence of myocardial infarction, stroke or cardiovascular death (the three point MACE) [7]
